Source comparison
GHRP-2 Acetate vs MK-677: Head-to-Head Comparison
Understanding the distinctions between GHRP-2 acetate and MK-677 is essential for selecting the correct compound for your research objectives. The table below compares pharmacokinetics, administration, research applications, and practical considerations. Compo
This comparison does not assign a generated winner or score.
- Understanding the distinctions between GHRP-2 acetate and MK-677 is essential for selecting the correct compound for your research objectives. The table below compares pharmacokinetics, administration, research applications, and practical considerations.
- Compound Class
- Synthetic hexapeptide (true peptide)
- Non-peptide ghrelin mimetic (secretagogue)
- GHRP-2 is a peptide requiring cold storage; MK-677 is chemically stable at room temperature
- Half-Life
- 20–30 minutes
- ~24 hours
- GHRP-2 produces acute pulsatile GH release; MK-677 sustains elevation across the dosing interval
- Administration
- Subcutaneous injection, 1–3x daily
- Oral (capsule/liquid), once daily
- MK-677 eliminates injection-related variability and improves protocol adherence in chronic studies
- GH Release Pattern
- Sharp pulsatile spike (15–30 min peak, cleared in 90–120 min)
- Sustained elevation across 24 hours
- Choose GHRP-2 for acute response studies; MK-677 for chronic anabolic signaling research
- IGF-1 Elevation
- Transient (peaks 4–8 hours, baseline by 12–16 hours)
- Sustained 40–90% above baseline for dosing duration
- MK-677 better suited for IGF-1-dependent endpoints like bone density or muscle protein synthesis
- Appetite Stimulation
- Transient (60–180 min post-injection)
- Sustained 20–30% caloric intake increase
- MK-677 introduces appetite as a confounding variable; GHRP-2 allows timed feeding schedules
- Storage & Stability
- Lyophilized: −20°C; reconstituted: 2–8°C for 28 days
- Room temperature stable
- MK-677 simplifies logistics in multi-site or long-duration research
- Typical Research Dose
- 100–300 mcg per injection
- 10–25 mg once daily
- Dosing precision easier with GHRP-2; MK-677 offers steady-state plasma levels
- Washout Period
- 12–24 hours (clears rapidly)
- 7–10 days to baseline
- GHRP-2 suitable for crossover designs; MK-677 requires longer washout in sequential protocols
- Ideal Research Context
- Acute metabolic challenge, pulsatile GH studies, crossover trials
- Chronic intervention (muscle mass, bone density, aging models)
- Match the compound's pharmacokinetic profile to your study's temporal design